Second messenger role for Mg2+ revealed by human T-cell immunodeficiency

Feng-Yen Li, Benjamin Chaigne-Delalande, Chrysi Kanellopoulou, Jeremiah C Davis, Helen F Matthews, Daniel C Douek, Jeffrey I Cohen, Gulbu Uzel, Helen C Su, Michael J Lenardo, Feng-Yen Li, Benjamin Chaigne-Delalande, Chrysi Kanellopoulou, Jeremiah C Davis, Helen F Matthews, Daniel C Douek, Jeffrey I Cohen, Gulbu Uzel, Helen C Su, Michael J Lenardo

Abstract

The magnesium ion, Mg(2+), is essential for all life as a cofactor for ATP, polyphosphates such as DNA and RNA, and metabolic enzymes, but whether it plays a part in intracellular signalling (as Ca(2+) does) is unknown. Here we identify mutations in the magnesium transporter gene, MAGT1, in a novel X-linked human immunodeficiency characterized by CD4 lymphopenia, severe chronic viral infections, and defective T-lymphocyte activation. We demonstrate that a rapid transient Mg(2+) influx is induced by antigen receptor stimulation in normal T cells and by growth factor stimulation in non-lymphoid cells. MAGT1 deficiency abrogates the Mg(2+) influx, leading to impaired responses to antigen receptor engagement, including defective activation of phospholipase Cγ1 and a markedly impaired Ca(2+) influx in T cells but not B cells. These observations reveal a role for Mg(2+) as an intracellular second messenger coupling cell-surface receptor activation to intracellular effectors and identify MAGT1 as a possible target for novel therapeutics.

Conflict of interest statement

The authors declare no competing financial interests.

Figures

Figure 1. Patients have a proximal TCR…
Figure 1. Patients have a proximal TCR activation defect
a, T cell CD4 and CD8 expression and ratio. b, CD31 expression in naïve CD4+ CD3+ T cells. c, CD69 expression in CD4+ T cells after 5 ug/ml anti-CD3 (αCD3) stimulation, PMA/Ionomycin (P/I) or unstimulated (Unstim). d, CD86 surface expression in purified B cells after stimulation with anti-IgM, SAC or unstimulated (Unstim). e, Confocal imaging of p65 nuclear translocation after αCD3 or P/I stimulation (scale bar: 10 μm). f, Percent cells with p65 (left) and NFAT (right) nuclear translocation. Numbers represent percent cells in indicated gates. Error bars represent s.e.m. (n=3), **** (P<0.0001).
Figure 2. Patients have MAGT1 null mutations…
Figure 2. Patients have MAGT1 null mutations and defective uptake of Mg2+
a, Pedigree of the families A (left) and B (right). b, X-chromosome inactivation assay. Peaks of PCR products from the different alleles are highlighted in yellow and pink. c, Schematic representation of the MAGT1 gene exons (boxes) and introns (lines), the mutations (*) and the probes used for RT-PCR. d, RT-PCR showing decreased expression of MAGT1 mRNA in T cells. e, Expression of MagT1 and actin control in T cells by immunoblot. f, Confocal images of T cells stained with anti-MagT1 antibody (scale bar: 5 μm).
Figure 3. TCR stimulation induces a MagT1-dependent…
Figure 3. TCR stimulation induces a MagT1-dependent Mg2+ influx
Mg2+ (upper panels) and Ca2+ (lower panels) flux: a, Fluxes in normal PBMC stimulated with ConA, PHA, αCD3, or αCD3/αCD28. b, Fluxes in healthy control T cells or Patient A.1 after 5 ug/ml αCD3 stimulation. c, Peak value of the fluxes in healthy control T cells and the 3 patients upon stimulation with indicated αCD3 concentrations. Error bars represent s.e.m. (n=3), **** (P<0.0001).
Figure 4. Requirement of receptor-stimulated Mg 2+…
Figure 4. Requirement of receptor-stimulated Mg2+ flux for signaling
a, Mg2+ (MagFluo4, upper panel) and Ca2+ (Ratio F3/FR, lower panel) flux in healthy control T cells stimulated with αCD3 in buffers containing 1mM Mg2+ and Ca2+ (control) or lacking either ion. b, Ca2+ flux in B cells stimulated with αIgM and αCD40. Calcimycin (Cal) and EDTA addition display control influx and ion chelation, respectively. c, Graphs represent the fold change of the peak of Mg2+ (upper panels) and Ca2+ (lower panels) flux in A549 cells either unstimulated (Unstim) or stimulated with epidermal growth factor (EGF) or carbachol (Carb) as indicated. Error bars represent s.e.m. (n=3).
Figure 5. Knockdown and rescue of MagT1
Figure 5. Knockdown and rescue of MagT1
Healthy T cells transfected with non-specific (NS) or MagT1 siRNAs. a, Mg2+ (MagFluo4, left) and Ca2+ (Fluo3, right) flux upon αCD3 stimulation. b, Percent nuclear p65 after MagT1 knockdown. Error bars represent s.e.m. (n=3). c, Time-lapse imaging (left, s = sec) or cytometry (right) of Mg2+ (upper) and Ca2+ (lower) flux in T cells transduced with lentiviruses expressing mCherry or mCherry + MagT1. d, Flow cytometry of CD69 expression on CD4+ T cells transduced with lentiviruses expressing MagT1 or not, either unstimulated (Unstim) or after anti-CD3 stimulation. Percent cells are shown for the indicated gates. Calcimycin (Cal) displays control influx.
Figure 6. MagT1 deficiency impairs PLCγ1 activation…
Figure 6. MagT1 deficiency impairs PLCγ1 activation upon TCR stimulation
a, Confocal images of TCR clustering induced by αCD3. Cells were stained for LAT, PLCγ1 or phospho-PLCγ1. (Scale bar: 5 μm). Immunoblot of the indicated signaling proteins and phosphoproteins (b) and quantification of cellular IP3 level (c) in healthy control and patient T cells stimulated with αCD3 for indicated times. Error bars represent s.e.m. (n=3). ****(P<0.0001). d, Hypothetical schematic depicting how the MagT1 mediated Mg2+ influx participates in TCR signaling. Solid arrows indicate direct effects; dotted arrows indicate indirect effects.

References

    1. Cakmak I, Kirkby EA. Role of magnesium in carbon partitioning and alleviating photooxidative damage. Physiol Plant. 2008;133:692–704.
    1. Cowan JA. Structural and catalytic chemistry of magnesium-dependent enzymes. Biometals. 2002;15:225–235.
    1. Yang W, Lee JY, Nowotny M. Making and breaking nucleic acids: two-Mg2+-ion catalysis and substrate specificity. Mol Cell. 2006;22:5–13.
    1. Gasser A, Bruhn S, Guse AH. Second messenger function of nicotinic acid adenine dinucleotide phosphate revealed by an improved enzymatic cycling assay. J Biol Chem. 2006;281:16906–16913.
    1. Grubbs RD, Maguire ME. Magnesium as a regulatory cation: criteria and evaluation. Magnesium. 1987;6:113–127.
    1. Murphy E. Mysteries of magnesium homeostasis. Circ Res. 2000;86:245–248.
    1. Permyakov EA, Kretsinger RH. Cell signaling, beyond cytosolic calcium in eukaryotes. J Inorg Biochem. 2009;103:77–86.
    1. Takaya J, Higashino H, Kobayashi Y. Can magnesium act as a second messenger? Current data on translocation induced by various biologically active substances. Magnes Res. 2000;13:139–146.
    1. Hogan PG, Lewis RS, Rao A. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu Rev Immunol. 28:491–533.
    1. Romani AM. Magnesium homeostasis in mammalian cells. Front Biosci. 2007;12:308–331.
    1. Abboud CN, Scully SP, Lichtman AH, Brennan JK, Segel GB. The requirements for ionized calcium and magnesium in lymphocyte proliferation. J Cell Physiol. 1985;122:64–72.
    1. Modiano JF, Kelepouris E, Kern JA, Nowell PC. Requirement for extracellular calcium or magnesium in mitogen-induced activation of human peripheral blood lymphocytes. J Cell Physiol. 1988;135:451–458.
    1. Whitney RB, Sutherland RM. The influence of calcium, magnesium and cyclic adenosine 3’,5’-monophosphate on the mixed lymphocyte reaction. J Immunol. 1972;108:1179–1183.
    1. Ng LL, Davies JE, Garrido MC. Intracellular free magnesium in human lymphocytes and the response to lectins. Clin Sci (Lond) 1991;80:539–547.
    1. Rijkers GT, Griffioen AW. Changes in free cytoplasmic magnesium following activation of human lymphocytes. Biochem J. 1993;289(Pt 2):373–377.
    1. Chun HJ, et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature. 2002;419:395–399.
    1. Notarangelo LD. Primary immunodeficiencies. J Allergy Clin Immunol. 2010;125:S182–194.
    1. Zhang Q, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361:2046–2055.
    1. Chan AC, et al. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science. 1994;264:1599–1601.
    1. Peterson EJ, Koretzky GA. Signal transduction in T lymphocytes. Clin Exp Rheumatol. 1999;17:107–114.
    1. Arpaia E, Shahar M, Dadi H, Cohen A, Roifman CM. Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase. Cell. 1994;76:947–958.
    1. Feske S, et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature. 2006;441:179–185.
    1. Unexplained CD4+ T-Lymphocyte Depletion in Persons Without Evident HIV Infection -- United States. MMWR Morb Mortal Wkly Rep. 1992;41:541–545.
    1. Laurence J, Siegal FP, Schattner E, Gelman IH, Morse S. Acquired immunodeficiency without evidence of infection with human immunodeficiency virus types 1 and 2. Lancet. 1992;340:273–274.
    1. Smith DK, Neal JJ, Holmberg SD. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med. 1993;328:373–379.
    1. Fauci AS. CD4+ T-lymphocytopenia without HIV infection--no lights, no camera, just facts. N Engl J Med. 1993;328:429–431.
    1. Freier S, et al. Hereditary CD4+ T lymphocytopenia. Arch Dis Child. 1998;78:371–372.
    1. Lin SJ, Chao HC, Yan DC, Kuo ML. Idiopathic CD4+ T lymphocytopenia in two siblings. Pediatr Hematol Oncol. 2001;18:153–156.
    1. Lobato MN, Spira TJ, Rogers MF. CD4+ T lymphocytopenia in children: lack of evidence for a new acquired immunodeficiency syndrome agent. Pediatr Infect Dis J. 1995;14:527–535.
    1. Junge S, et al. Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children. Eur J Immunol. 2007;37:3270–3280.
    1. Kimmig S, et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med. 2002;195:789–794.
    1. Kohler S, Thiel A. Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets. Blood. 2009;113:769–774.
    1. Wengler GS, et al. A PCR-based non-radioactive X-chromosome inactivation assay for genetic counseling in X-linked primary immunodeficiencies. Life Sci. 1997;61:1405–1411.
    1. Goytain A, Quamme GA. Identification and characterization of a novel mammalian Mg2+ transporter with channel-like properties. BMC Genomics. 2005;6:48.
    1. Quamme GA. Molecular identification of ancient and modern mammalian magnesium transporters. Am J Physiol Cell Physiol. 2009;298:C407–429.
    1. Zhou H, Clapham DE. Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development. Proc Natl Acad Sci U S A. 2009;106:15750–15755.
    1. Xie Z, Peng J, Pennypacker SD, Chen Y. Critical role for the catalytic activity of phospholipase C-gamma1 in epidermal growth factor-induced cell migration. Biochem Biophys Res Commun. 2010;399:425–428.
    1. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell. 1994;76:263–274.
    1. Nel AE. T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J Allergy Clin Immunol. 2002;109:758–770.
    1. Sutherland EW. Studies on the mechanism of hormone action. Science. 1972;177:401–408.
    1. Flynn A. Control of in vitro lymphocyte proliferation by copper, magnesium and zinc deficiency. J Nutr. 1984;114:2034–2042.
    1. Sabbagh F, Lecerf F, Hulin A, Bac P, German-Fattal M. Effect of hypomagnesemia on allogeneic activation in mice. Transpl Immunol. 2008;20:83–87.
    1. Jin J, et al. Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering Mg2+ homeostasis. Science. 2008;322:756–760.
    1. Cossu F. Genetics of SCID. Ital J Pediatr. 36:76.
    1. Filipovich AH, Zhang K, Snow AL, Marsh RA. X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood. 116:3398–3408.
    1. Fu G, et al. Phospholipase C{gamma}1 is essential for T cell development, activation, and tolerance. J Exp Med. 2010;207:309–318.
    1. Crabtree GR. Contingent genetic regulatory events in T lymphocyte activation. Science. 1989;243:355–361.

Source: PubMed

3
Abonner